Navigation Links
Cenestra Health Announces Granting of Broad Patent Covering Proprietary Bioactive Lipid Formulations
Date:12/8/2011

rable investment in product development, and sales and marketing.  From the data Cenestra has generated to date, we expect the products developed under the Cenestra patents will confer superior efficacy to those currently on the market or announced to be in development," stated Dr. Sanfilippo. 

About Cenestra, LLC (D/B/A Cenestra Health)

Cenestra Health is a privately-held and unleveraged biopharmaceutical company based in New Haven, Connecticut. Cenestra Health was founded in 2005 to formulate, develop and market "best-in-class" proprietary natural products with applications in the OTC, medical food and pharmaceutical markets. Cenestra Health is focused on the clinical development of its late stage clinical drug candidates for the treatment of dyslipidemias and central nervous system disorders. Cenestra Health is planning to initiate Phase 3 registrational trials in early 2012.

About Omega-3 Essential Fatty Acids

Omega-3 fatty acids are considered "essential" fatty acids (EFAs) as they are necessary to human health but cannot be produced by the body. The two major health promoting omega-3 polyunsaturated fatty acids are eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). EPA and DHA have been shown to promote good physical and emotional health, reduce the risk of cardiovascular disease, and exert powerful anti-inflammatory effects. Omega-3 prescriptions in the United States alone accounted for over $1 billion dollars in sales in 2010.

Statements made in this press release should not to be construed as making any specific claim or claims in the diagnosis, prevention or treatment of any disease or disorder but  may relate to historical facts and information that reflect forward looking statements based on Cenestra Health's intellectual property and scientific data.    

  
Investor Contact:  Louis Sanfilippo, M.D., Managing Director
Email: '/>"/>

SOURCE Cenestra Health
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Cenestra Health Issued Notice of Allowance: Expands Patent Range of High-Purity Omega-3 Fatty Acid Formulations
2. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2008
3. SCAN Health Plan Offers Seniors Five Tips to Prepare for Surgery
4. Mergent, Inc. Announces Changes to the HealthShares(TM) European Drugs Index
5. Concentric Medical(R) Announces Co-Marketing Agreement With InTouch Health(R) to Advance Acute Ischemic Stroke Care
6. Mindray Medical to Attend Morgan Stanley Global Healthcare Unplugged Conference
7. BioNeutrals Ygiene(TM) New Hospital Grade Disinfectant Will Save Lives and Billions of Dollars Annually at Health Care Facilities Around the World
8. RF Technologies(R) Installs Safe Place(R) Solution for Pediatric and Infant Security at ProHealth Cares Waukesha Memorial Hospital
9. Rosetta Genomics and the National Institute of Health (NIH) to Identify Potential MicroRNA Drug Targets for HIV
10. Inc. Magazine Names Senior Whole Health the Number One Fastest-Growing Private Company in US
11. TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... Diagnostics Inc. (TSX:V: SQD), a life sciences company that ... advanced microarray diagnostics, today announced it has appointed ... team. In his capacity as CFO he will ... development stage to a commercially successful company including ... market strategy and to secure funding to drive ...
(Date:3/3/2015)... N.J. , March 3, 2015  Regenicin, Inc. ... company specializing in the development of and commercialization of ... tissues and organs, announced today that it has received ... with Amarantus Bioscience Holdings, Inc. (OTC Bulletin Board: ... the Agreement, Amarantus made the final payments due to ...
(Date:3/3/2015)...  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or ... Expert Opinion on Biological Therapy , Dr. Michael ... , at the Henry Ford Hospital in ... (TB4) has the capacity to promote CNS and peripheral ... leading to neurological recovery in each case.  They pointed ...
(Date:3/3/2015)... March 3, 2015 Kindred Biosciences, Inc. (NASDAQ: ... improving the lives of pets, announced today that it will ... March 12, 2015 after the market close. The Company will ... day. Interested parties may access the call ... 756-4262 internationally, and using conference ID 98449349.  ...
Breaking Biology Technology:SQI Diagnostics Appoints Chief Financial Officer 2SQI Diagnostics Appoints Chief Financial Officer 3Regenicin (RGIN) Receives $2.3 Million in Final Payment from Amarantus 2Regenicin (RGIN) Receives $2.3 Million in Final Payment from Amarantus 3Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 2Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 3
... Nov. 16, 2010 Reportlinker.com announces that a ... catalogue: Global Specialty Enzymes Industry ... This report analyzes the worldwide markets for Specialty ... segments - Specialty Medical Enzymes, Polymerases, Nucleases, and ...
... by researchers from Imperial College London, involves a new ... engineered to distort light or sound waves. With conventional ... with metamaterials, scientists can exploit a wealth of additional ... parts of the electromagnetic spectrum, an image can be ...
... 2010 Palatin Technologies, Inc. (NYSE Amex: PTN ... mimetic and small molecule agonist compounds with a focus on ... its first quarter ended September 30, 2010. Palatin reported a ... diluted share, for the quarter ended September 30, 2010, compared ...
Cached Biology Technology:Reportlinker Adds Global Specialty Enzymes Industry 2Reportlinker Adds Global Specialty Enzymes Industry 3Reportlinker Adds Global Specialty Enzymes Industry 4Reportlinker Adds Global Specialty Enzymes Industry 5Reportlinker Adds Global Specialty Enzymes Industry 6Reportlinker Adds Global Specialty Enzymes Industry 7Reportlinker Adds Global Specialty Enzymes Industry 8Reportlinker Adds Global Specialty Enzymes Industry 9Reportlinker Adds Global Specialty Enzymes Industry 10Reportlinker Adds Global Specialty Enzymes Industry 11Reportlinker Adds Global Specialty Enzymes Industry 12Reportlinker Adds Global Specialty Enzymes Industry 13Reportlinker Adds Global Specialty Enzymes Industry 14Reportlinker Adds Global Specialty Enzymes Industry 15Reportlinker Adds Global Specialty Enzymes Industry 16Reportlinker Adds Global Specialty Enzymes Industry 17Reportlinker Adds Global Specialty Enzymes Industry 18Reportlinker Adds Global Specialty Enzymes Industry 19Reportlinker Adds Global Specialty Enzymes Industry 20Reportlinker Adds Global Specialty Enzymes Industry 21Reportlinker Adds Global Specialty Enzymes Industry 22Reportlinker Adds Global Specialty Enzymes Industry 23Reportlinker Adds Global Specialty Enzymes Industry 24'Space-time cloak' to conceal events revealed in new study 2'Space-time cloak' to conceal events revealed in new study 3Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2011 Results; Teleconference and Webcast to be held on November 16, 2010 2Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2011 Results; Teleconference and Webcast to be held on November 16, 2010 3Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2011 Results; Teleconference and Webcast to be held on November 16, 2010 4
(Date:2/5/2015)... Jan. 30, 2015  It is gratifying to see ... potential for genomic science as a means to better ... and treatment.  I was honored to participate in today,s ... medicine program. Since the 1980s my ... genomics—from the first sequenced genome of a free living ...
(Date:1/22/2015)... 9, 2015 Valid S.A. ("Company") (BM&FBOVESPA: VLID3 ON), is ... the State of Washington,s Department of ... enrollment and central issuance system for driver,s licenses and identification ... project planning and development will start in January 2015, with ...
(Date:1/22/2015)... Jan. 13, 2015 Technology Showcase, Hall E -   ... solutions, today announced it will showcase its EyeLock ID technology ... the Department of Energy,s Oak Ridge National Laboratory ... . EyeLock,s iris identity authentication technology is being used to ...
Breaking Biology News(10 mins):J. Craig Venter, Ph.D., Co-Founder and CEO, Human Longevity, Inc. (HLI) Participates in White House Precision Medicine Event 2Valid USA Signs Contract For Washington Driver's License Issuance 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 3
... dramatically better computer tool for finding the genetic missteps ... Children,s Research Hospital Washington University Pediatric Cancer Genome ... help identify the chromosomal rearrangements and DNA insertions or ... is known as CREST, short for Clipping Reveals Structure. ...
... announces that a new market research report is available ... Microarrays and Lab-on-a-Chip http://www.reportlinker.com/p0170497/Global-Biochip-Markets-Microarrays-and-Lab-on-a-Chip.html ... STUDY GOALS AND OBJECTIVES BCC,s goal ... current and emerging biochip technologies and products, and assess ...
... An outbreak of Escherichia coli causing a severe illness ... 2011 and has killed more than 20 people and sickened ... identified as a strain of E. coli O104:H4 ... to infection with E. coli O157:H7. Two isolates ...
Cached Biology News:Researchers improve method for finding genetic mistakes that fuel cancer 2Researchers improve method for finding genetic mistakes that fuel cancer 3Reportlinker Adds Global Biochip Markets: Microarrays and Lab-on-a-Chip 2Reportlinker Adds Global Biochip Markets: Microarrays and Lab-on-a-Chip 3Reportlinker Adds Global Biochip Markets: Microarrays and Lab-on-a-Chip 4Reportlinker Adds Global Biochip Markets: Microarrays and Lab-on-a-Chip 5Reportlinker Adds Global Biochip Markets: Microarrays and Lab-on-a-Chip 6Reportlinker Adds Global Biochip Markets: Microarrays and Lab-on-a-Chip 7Reportlinker Adds Global Biochip Markets: Microarrays and Lab-on-a-Chip 8Reportlinker Adds Global Biochip Markets: Microarrays and Lab-on-a-Chip 9Reportlinker Adds Global Biochip Markets: Microarrays and Lab-on-a-Chip 10Reportlinker Adds Global Biochip Markets: Microarrays and Lab-on-a-Chip 11Reportlinker Adds Global Biochip Markets: Microarrays and Lab-on-a-Chip 12Reportlinker Adds Global Biochip Markets: Microarrays and Lab-on-a-Chip 13Reportlinker Adds Global Biochip Markets: Microarrays and Lab-on-a-Chip 14Reportlinker Adds Global Biochip Markets: Microarrays and Lab-on-a-Chip 15Two isolates from E. coli outbreak available 2
... We deliversoluble protein or No Charge to ... best soluble protein results , 24 solubility ... , Powerful results on your most insoluble ... Service (SOS) uses proprietary tools and know-how ...
... scale kinase profiling, quantitative measurement of ... research built on the flexible and ... These microarrays are available as part ... - Peptide Microarray Service. ...
... Microarrays designed for immunological studies, ... on the flexible and powerful Paraflo ... are available as part of our ... Custom Probe Content Probe ...
... Molecular Imaging (MI) Software for use in ... and drug discovery applications. The Regulatory Edition ... Drug Administrations Code of Federal Regulations Title ... [21 CFR Part 11]. KODAK MI Software, ...
Biology Products: